← All market papers

Outpatient & Home Infusion Referral Market Paper

Medicare infusion administration and infused biologics · states · rheumatology, GI, neurology and ID/OPAT pathways

The Medicare infusion market by drug, administration code and state, plus four referral-source pathways sized from the biologics and IV therapies prescribing specialists bill. ID/OPAT Medicare dollars understate that market because most home IV antibiotics are billed outside Part B.

Built for Ambulatory infusion center operators, home infusion liaisons, specialty pharmacy teams and infusion investors.

See our sources

What's inside the full paper

  • Executive summary
  • Infusion codes nationally
  • State ranking
  • Referral pathway: Rheumatology infusion referral sources (RA, lupus, spondyloarthritis)
  • Referral pathway: GI infusion referral sources (Crohn's and ulcerative colitis)
  • Referral pathway: Neurology infusion referral sources (MS, myasthenia, CIDP)
  • Referral pathway: Infectious disease / OPAT referral sources (IV antibiotics)
  • How to use this with RepVector
  • Methods and limits

Free preview

Executive summary

Prepared 2026-11-22 from the CMS Medicare Physician & Other Practitioners by Geography and Service file (latest release), read live. Across 15 infusion administration and infused-drug codes, Original Medicare paid an estimated $2,453,266,763.

The largest states are Florida ($277,392,773), Texas ($210,816,640), California ($181,793,787), New York ($117,054,131), North Carolina ($112,785,330). The top five hold 36.7% of the national total.

This paper also sizes 4 referral-source pathways (rheumatologists; gastroenterologists; neurologists; infectious disease physicians and hospitalists) by the procedures and drugs those clinicians bill. These identify prospects to call on, not confirmed referrers or referral volume.

Infusion codes nationally

Providers and beneficiaries are the larger of the office/facility rows per code, not a sum. Payment = CMS average Medicare payment × services.

CodeDescriptionProvidersBeneficiariesServicesMedicare payment
J0129Injection, abatacept, 10 mg (code may be used for medicare when drug a4,25225,59616,527,204$554,799,816
J3380Injection, vedolizumab, intravenous, 1 mg5,59211,31919,489,392$334,780,924
J3262Injection, tocilizumab, 1 mg3,70914,16256,601,164$263,325,890

12 more rows in the full paper

State ranking

Rendering-provider state. Billing providers is the largest single-code count (providers bill several codes, so they are not summed).

StateBilling providersServicesMedicare paymentShare
Florida1,92613,555,245$277,392,77311.3%
Texas2,1259,651,533$210,816,6408.6%
California2,2818,981,168$181,793,7877.4%

53 more rows in the full paper

Statistical results are review leads, not findings of fraud. See our sources.